Nanotechnology’s promise will ‘crumble to ashes’ if regulation doesn’t ensure products are safe before reaching the market, according to a Swedish MEP.
The cosmetic industry should avoid a ‘strategy of silence’ when it comes to nanotechnology, according to a recent report from the International Risk Governance Council (IRGC).
RCP Therapeutics is set to recieve significant investment from a US-based venture capital firm which will lead to the spin off of a new company dedicated to cosmeceuticals.
